Therefore, DEP induction of CYP1B1 at the BBB may bioactivate PAHs adsorbed to DEP into genotoxic intermediates [44,45] that could increase levels of potentially harmful chemicals, which may initiate BBB dysfunction and/or brain disease. This evidence concerns the gene CYP1B1 and brain disorder.